Paolo Mannelli

8PUBLICATIONS
3CO-AUTHORS
Social psychologyRegenerative medicine (incl. stem cells)Counselling psychologyClinical pharmacy and pharmacy practiceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 13, 2025
The role of negative thinking and catastrophizing in the ordinary experience of withdrawal from substances.

Paolo Mannelli

|Sep 23, 2024
Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions.

Paolo Mannelli

|Feb 09, 2022
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended-release naltrexone in a residential setting.

Paolo Mannelli, Antoine B Douaihy, Sarah C Akerman

|Jan 11, 2021
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.

Li-Tzy Wu, William S John, Udi E Ghitza

|Apr 05, 2020
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.

Sandra D Comer, Paolo Mannelli, Danesh Alam

|Jun 28, 2019
Commentary on Winhusen et al. (2019): Substance use disorders, chronic diseases, and electronic health records-a paradigm for screening and intervention.

Paolo Mannelli, Li-Tzy Wu

Pageof 2

Frequent Collaborators

1 joint publications

Adam Bisaga

1 joint publications

Li-Tzy Wu

1 joint publications

Udi E Ghitza